XML 65 R49.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Summary of Non-Qualified Stock Options (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Stock Appreciation Rights (SARs) [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 791,627   818,284
Granted (in shares) 0    
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised (26,413)    
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures (244)    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 790,495    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $ 59.40   $ 59.55
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 0    
Weighted Average Exercise Price, Exercises in Period (in dollars per share) 63.82    
Weighted Average Exercise Price, Forfeitures in Period (in dollars per share) 85.35    
Weighted Average Exercise Price, Exercisable (in dollars per share) $ 59.37    
Weighted Average Remaining Contractual Term, Outstanding (in years) 4 years 9 months 18 days    
Aggregate Intrinsic Value, Outstanding $ 88.6    
Weighted Average Remaining Contractual Term, Exercisable (in years) 4 years 9 months 18 days    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $ 88.5    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value $ 2.8    
Share-based Payment Arrangement, Option      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 241,854   163,082
Granted (in shares) 85,425 75,182  
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised (2,326)    
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures (4,327)    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 77,608    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $ 147.20   $ 144.51
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 152.07    
Weighted Average Exercise Price, Exercises in Period (in dollars per share) 122.09    
Weighted Average Exercise Price, Forfeitures in Period (in dollars per share) 155.67    
Weighted Average Exercise Price, Exercisable (in dollars per share) $ 136.81    
Weighted Average Remaining Contractual Term, Outstanding (in years) 8 years 10 months 24 days    
Aggregate Intrinsic Value, Outstanding $ 5.9    
Weighted Average Remaining Contractual Term, Exercisable (in years) 8 years 2 months 12 days    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $ 2.7